Radiation plus immunotherapy shows promise in advanced cancers
NCT ID NCT03313804
First seen Mar 15, 2026 · Last updated Jun 12, 2026 · Updated 9 times
Summary
This study looked at 76 people with advanced non-small cell lung cancer or head and neck squamous cell cancer who were already starting immunotherapy. Within two weeks of their first dose, they received a short course of radiation to one tumor site. The goal was to see if this combination could improve the number of patients whose cancer did not get worse after six months, compared to historical data. The approach aims to help the immune system recognize and attack the cancer more effectively.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Kentucky Markey Cancer Center
Lexington, Kentucky, 40536, United States
Conditions
Explore the condition pages connected to this study.